Specifically, there is a potential role for CCR7 in colorectal cancer progression based on the overexpression of CCR7 ligand CCL21 observed in the inflammatory bowel disease, ulcerative colitis [106,107,108]. Here, CCR7 is linked to inflammatory bowel disease.